What is Rapport Therapeutics, Inc.'s accounts payable?

Rapport Therapeutics, Inc. (RAPP) reported accounts payable of $6.56M in Q1 2026.

How has Rapport Therapeutics, Inc.'s accounts payable changed year-over-year?

Rapport Therapeutics, Inc.'s accounts payable increased by 206.7% year-over-year, from $2.14M to $6.56M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Rapport Therapeutics, Inc. RAPP Accounts Payable

Accounts Payable at other companies

Bristol-Myers SquibbBMY

$4.23B+5.8%

Xenon PharmaceuticalsXENE

$38.25M+24.8%

Praxis Precision Medicines, Inc.PRAX

$31.16M+36.0%

BiohavenBHVN

$10.42M-45.6%

Septerna, Inc.SEPN

$7.46M+71.6%

PVL

Palvella TherapeuticsPVLA

$5.44M+22.6%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s accounts payable?: Rapport Therapeutics, Inc. (RAPP) reported accounts payable of $6.56M in Q1 2026.
How has Rapport Therapeutics, Inc.'s accounts payable changed year-over-year?: Rapport Therapeutics, Inc.'s accounts payable increased by 206.7% year-over-year, from $2.14M to $6.56M.
What does accounts payable mean?: Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.